The pharmaceutical sector continued to recover in the afternoon, and the Hong Kong Stock Connect Innovation Drug ETF E Fund (159316) had a net subscription of 56 million shares throughout the day.

NightAirdropper · 2026-03-11T23:13:53+00:00

Biotechnology-related indices generally declined today, but funds are investing against the trend, with the Hong Kong Stock Connect Innovative Drug ETF net subscriptions reaching 56 million shares. The government work report for the first time listed biomedicine as an emerging pillar industry, signaling an important policy move to promote industry upgrading.

NightAirdropper

2026-03-11 23:13:53

Abstract generation in progress

As of the close, the CSI Biotech Index fell 1.0%, the CSI 300 Healthcare Index declined 1.2%, the Hang Seng Hong Kong Stock Connect Innovative Drug Index and the CSI Innovative Drug Industry Index both dropped 1.4%, and the CSI Hong Kong Stock Connect Healthcare Composite Index decreased 1.6%. Despite the downturn, funds were actively deployed, with the Harvest Hong Kong Stock Connect Innovative Drug ETF (159316, Connect Fund A/C: 024328/024329) experiencing a net purchase of 56 million units throughout the day.

According to reports, this year’s government work report explicitly listed biomedicine as a “new pillar industry” at the national level, alongside industries such as integrated circuits, aerospace, and the low-altitude economy. This is the first time the development of the biomedicine industry has been proposed as a pillar industry in the government work report, signaling an important policy move to accelerate industry upgrading.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.